Adaptive Biotechnologies Corp - Common Stock (ADPT)

CUSIP: 00650F109

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock
Shares outstanding
151,803,139
Total 13F shares
101,046,823
Share change
+4,112,042
Total reported value
$4,886,712,149
Put/Call ratio
58%
Price per share
$48.38
Number of holders
192
Value change
+$212,566,003
Number of buys
120
Number of sells
60

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 00650F109?
CUSIP 00650F109 identifies ADPT - Adaptive Biotechnologies Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ADPT - Adaptive Biotechnologies Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VIKING GLOBAL INVESTORS LP
13F
Company
22%
33,493,708
$930,455,000 31 Mar 2020
13F
Matrix Capital Management Company, LP
13F
Company
10%
15,115,090
$419,897,000 31 Mar 2020
13F
BlackRock Finance, Inc.
13F
Company
3.3%
4,960,832
$137,812,000 31 Mar 2020
13F
VANGUARD GROUP INC
13F
Company
2.9%
4,471,781
$124,225,000 31 Mar 2020
13F
Senator Investment Group LP
13F
Company
2.2%
3,388,085
$94,121,000 31 Mar 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.2%
3,303,520
$91,772,000 31 Mar 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
2.1%
3,243,245
$90,097,000 31 Mar 2020
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
1.5%
2,279,250
$63,318,000 31 Mar 2020
13F
Artisan Partners Limited Partnership
13F
Company
1.2%
1,873,035
$52,033,000 31 Mar 2020
13F
TimesSquare Capital Management, LLC
13F
Company
1.1%
1,675,590
$46,548,000 31 Mar 2020
13F
Capital International Investors
13F
Company
1%
1,522,104
$42,284,000 31 Mar 2020
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.98%
1,488,657
$41,354,000 31 Mar 2020
13F
TIGER MANAGEMENT L.L.C.
13F
Company
0.73%
1,115,411
$30,986,000 31 Mar 2020
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.62%
946,710
$26,300,000 31 Mar 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.58%
884,934
$24,584,000 31 Mar 2020
13F
Casdin Capital, LLC
13F
Company
0.52%
793,125
$22,033,000 31 Mar 2020
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
0.49%
746,896
$20,748,000 31 Mar 2020
13F
BAKER BROS. ADVISORS LP
13F
Company
0.49%
743,734
$20,661,000 31 Mar 2020
13F
STATE STREET CORP
13F
Company
0.47%
713,896
$19,832,000 31 Mar 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.44%
675,120
$18,754,000 31 Mar 2020
13F
ZEVENBERGEN CAPITAL INVESTMENTS LLC
13F
Company
0.43%
658,650
$18,298,000 31 Mar 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.4%
607,588
$16,879,000 31 Mar 2020
13F
Rock Springs Capital Management LP
13F
Company
0.36%
545,000
$15,140,000 31 Mar 2020
13F
Robertson Stephens Wealth Management, LLC
13F
Company
0.35%
537,095
$14,920,000 31 Mar 2020
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.35%
525,404
$14,596,000 31 Mar 2020
13F
BAMCO INC /NY/
13F
Company
0.34%
514,474
$14,292,000 31 Mar 2020
13F
Neuberger Berman Group LLC
13F
Company
0.33%
497,845
$13,830,000 31 Mar 2020
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.33%
495,000
$13,424,000 31 Mar 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.31%
467,236
$12,979,000 31 Mar 2020
13F
FMR LLC
13F
Company
0.3%
462,181
$12,840,000 31 Mar 2020
13F
Redmile Group, LLC
13F
Company
0.27%
414,400
$11,512,000 31 Mar 2020
13F
DEUTSCHE BANK AG\
13F
Company
0.27%
405,703
$11,270,000 31 Mar 2020
13F
PEREGRINE CAPITAL MANAGEMENT LLC
13F
Company
0.25%
385,590
$10,712,000 31 Mar 2020
13F
NORTHERN TRUST CORP
13F
Company
0.25%
374,551
$10,404,000 31 Mar 2020
13F
Aristotle Atlantic Partners, LLC
13F
Company
0.24%
370,841
$10,302,000 31 Mar 2020
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.22%
332,671
$9,243,000 31 Mar 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.16%
236,121
$6,560,000 31 Mar 2020
13F
Invesco Ltd.
13F
Company
0.15%
224,819
$6,245,000 31 Mar 2020
13F
MORGAN STANLEY
13F
Company
0.15%
224,382
$6,233,000 31 Mar 2020
13F
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC
13F
Company
0.14%
217,442
$6,041,000 31 Mar 2020
13F
Artal Group S.A.
13F
Company
0.13%
200,000
$5,556,000 31 Mar 2020
13F
KORNITZER CAPITAL MANAGEMENT INC /KS
13F
Company
0.13%
198,120
$5,504,000 31 Mar 2020
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.13%
195,000
$5,417,000 31 Mar 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0.12%
183,773
$5,107,000 31 Mar 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.11%
168,789
$4,689,000 31 Mar 2020
13F
CWM, LLC
13F
Company
0.07%
103,941
$4,247,000 31 Mar 2020
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
0.1%
150,500
$4,181,000 31 Mar 2020
13F
Iron Triangle Partners LP
13F
Company
0.1%
150,000
$4,167,000 31 Mar 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.1%
146,356
$4,066,000 31 Mar 2020
13F
Bank of New York Mellon Corp
13F
Company
0.09%
144,165
$4,005,000 31 Mar 2020
13F

Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q2 2020

As of 30 Jun 2020, Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by 192 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 101,046,823 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, Matrix Capital Management Company, LP, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, GILDER GAGNON HOWE & CO LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Artisan Partners Limited Partnership, Neuberger Berman Group LLC, and Senator Investment Group LP. This page lists 192 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
144
Q2 2020 holders
192
Holder diff
48
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.